about
Nanoparticle-based monitoring of cell therapy.HER2 targeted molecular MR imaging using a de novo designed protein contrast agentAptamer-crosslinked microbubbles: smart contrast agents for thrombin-activated ultrasound imaging.Coronary microvascular resistance: methods for its quantification in humansHyperpolarized water as an MR imaging contrast agent: feasibility of in vivo imaging in a rat modelNanoparticles for biomedical imagingAdvances in lymphatic imaging and drug delivery.Magnetic Nanoparticles: Material Engineering and Emerging Applications in Lithography and Biomedicine.Copper-64 Radiopharmaceuticals for Oncologic ImagingA review of imaging agent development.Toxicity of therapeutic nanoparticles.Cardiovascular molecular imaging: an overview.Current and future lymphatic imaging modalities for tumor stagingCombining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis.Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics.Perspectives and potential applications of nanomedicine in breast and prostate cancer.Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agentsSynthesis route and three different core-shell impacts on magnetic characterization of gadolinium oxide-based nanoparticles as new contrast agents for molecular magnetic resonance imaging.Size reproducibility of gadolinium oxide based nanomagnetic particles for cellular magnetic resonance imaging: effects of functionalization, chemisorption and reaction conditions.Development and optimization of hardware for delta relaxation enhanced MRI.Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents.Analysis of polyvinyl alcohol microbubbles in human blood plasma using capillary electrophoresis.Design and Fabrication of an MRI-Compatible, Autonomous Incubation System.Recent advances and future prospects of iron oxide nanoparticles in biomedicine and diagnostics.Iron Oxides and Their Silica Nanocomposites as Biocompatible Systems for Biomedical ApplicationsMagnetic targeting for site-specific drug delivery: applications and clinical potentialLanthanide Loaded Zeolites, Clays, and Mesoporous Silica Materials as MRI ProbesFluorescent-magnetic poly(poly(ethyleneglycol)monomethacrylate)-grafted Fe3O4 nanoparticles from post-atom-transfer-radical-polymerization modification: synthesis, characterization, cellular uptake and imagingApplication of Plant Viruses as a Biotemplate for Nanomaterial Fabrication
P2860
Q27000646-E46A80DD-04E3-4D5D-A689-171473569DCDQ28477503-621E5946-3409-421A-94D5-2031F34C2A56Q30446764-0D6F66E4-BC89-424C-B184-E0108A0F19E6Q30487553-7568221E-6027-4010-93C2-130A478D9532Q30569663-F62BEA1D-0A26-4C7D-AA12-0D251004F953Q34989401-583D48D5-AED4-4E79-91FC-5D326EB940C5Q35188498-44F539A7-E61A-400D-BF29-19C606FFA2A0Q36283461-886362D8-1297-4C9D-B087-31A6F95208E2Q37126530-9E1ADD9D-F3F7-4E35-9462-3E213E040EC8Q37214528-DB7AAA69-0726-4BE4-97D5-708F273DEE6BQ37385444-8DE7B199-D282-43F1-91B5-85CE5678C2F9Q37530107-B1A585AF-07F4-4F2E-B563-6EFF1F675D4FQ37686649-C402D16B-7510-4646-9673-0E06B89476ACQ37696318-CD11E680-6E85-4DA3-B3AA-8C4DD78A403AQ37772453-2F141708-9C74-4919-891F-DDBEB0E58905Q37871989-7F556E3F-AE23-4A14-ACB0-3785BE376E65Q38067306-2CA4CF32-D5FB-4D1E-85F3-7A99BA8303F0Q38199539-5BABB347-D91F-4A5B-8CDA-A2083D20EE05Q39804161-2D94E2B5-D4DF-4601-8A71-870CFDAE7932Q41127223-BC9B46B3-E6B6-411F-B038-177363BE11FAQ42268414-51822201-BF06-4CB1-9309-E2CD3E116C5CQ45383858-F51CF51C-301D-431F-874C-5743BB8D937EQ50543296-0FCB7169-823D-4AF9-BAE3-D995F7EF3F6AQ51495278-D6579616-EAA0-40FA-B860-C613910C395BQ53586096-55E78D21-C8CC-4532-B892-FB85BBF74FD9Q55001915-74337AAB-3298-4A82-80E2-462CD63D2349Q57345684-1A43E44D-A298-4BC7-9510-6F9E16BA725FQ57381726-8F305C91-E20A-45A7-8D5B-397C0E9A371AQ57391322-F6036668-06C0-4C88-A829-AF290C6CB524Q58654122-FACAA78F-0E48-4DD2-95D8-EE482F12D346Q58696447-E84BE2DC-7239-4455-8F2B-44C6FD00C874
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contrast agents for MRI.
@en
Contrast agents for MRI.
@nl
type
label
Contrast agents for MRI.
@en
Contrast agents for MRI.
@nl
prefLabel
Contrast agents for MRI.
@en
Contrast agents for MRI.
@nl
P1476
Contrast agents for MRI.
@en
P2093
Emily A Waters
Samuel A Wickline
P2860
P2888
P304
P356
10.1007/S00395-008-0711-6
P577
2008-03-01T00:00:00Z